Abstract
BackgroundThe spondyloarthritis (SpA) patients treated under TNF inhibitors (TNFi) with detectable antidrug antibodies (ADA) often develop loss of efficacy. Concomitant therapy with methotrexate (MTX) appears to reduce the the immunogenicity...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have